Related content

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

By Andrezina Raisa   Josiassen Richard   Marcus Ronald   Oren Dan   Manos George   Stock Elyse   Carson William   Iwamoto Taro  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 281-292

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder

By Gunasekara N.S.   Spencer C.M.   Keating G.M.  

CNS Drugs, Vol. 16, Iss. 9, 2002-01 ,pp. : 645-652

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison   Scott Lesley J.  

CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. : 1027-1052

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Gunasekara N.S.   Spencer C.M.   Keating G.M.  

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1217-1251

Adis International

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite